Tesla faces a critical pivot as it balances record vehicle deliveries and software growth against a 1.4% operating margin and heavy capital expenditure, with the stock's path to $550 hinging on successful Robotaxi scaling.
Record deliveries, FSD subscription growth, and Robotaxi scaling present a potential catalyst despite Q2 margin compression and negative free cash flow.
Tesla shares are down 21% year-to-date at $357.24, despite record deliveries of 480,126 vehicles and a 56% surge in FSD subscriptions. While the company faces significant margin compression and negative free cash flow due to a $25 billion capex push, bulls point to Robotaxi expansion and Optimus manufacturing as potential catalysts for a long-term recovery toward a $550 price target.
The primary risks include severe margin compression, negative free cash flow resulting from high capital expenditures exceeding $25 billion, and the potential for macro-economic volatility given the stock's high beta of 1.845.